糖尿病治疗-话题@MedSci

#糖尿病治疗#

114篇内容 | 3095人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1989908, encodeId=3687198990839, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=J Diabetes：糖尿病治疗模式变革即将到来？, objectType=article, longId=14035, objectId=e693140357e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e693140357e, replyNumber=0, likeNumber=0, createdTime=2013-01-22, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e693140357e, moduleTitle=J Diabetes：糖尿病治疗模式变革即将到来？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e693140357e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989903, encodeId=f4da198990380, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=Cell Metab：胰岛细胞酶蛋白Bace2成糖尿病治疗新药靶, objectType=article, longId=4123, objectId=531d412390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=531d412390, replyNumber=0, likeNumber=64, createdTime=2012-12-11, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=531d412390, moduleTitle=Cell Metab：胰岛细胞酶蛋白Bace2成糖尿病治疗新药靶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=531d412390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989906, encodeId=68ce198990625, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=Lancet：质量改善策略可改善糖尿病治疗, objectType=article, longId=7217, objectId=3345e21754, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3345e21754, replyNumber=0, likeNumber=68, createdTime=2012-08-22, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3345e21754, moduleTitle=Lancet：质量改善策略可改善糖尿病治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3345e21754)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989907, encodeId=fd59198990eac, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=Cell Metab：TXNIP分子为糖尿病治疗提供新的靶点, objectType=article, longId=8932, objectId=73e9893235, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73e9893235, replyNumber=0, likeNumber=76, createdTime=2012-10-21, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73e9893235, moduleTitle=Cell Metab：TXNIP分子为糖尿病治疗提供新的靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73e9893235)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989900, encodeId=74d6198990014, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=成人2型糖尿病治疗药物Jentadueto获FDA批准, objectType=article, longId=4056, objectId=a95d405694, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a95d405694, replyNumber=0, likeNumber=77, createdTime=2012-12-18, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a95d405694, moduleTitle=成人2型糖尿病治疗药物Jentadueto获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a95d405694)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989905, encodeId=476519899059b, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=PNAS：糖尿病治疗新药靶, objectType=article, longId=6546, objectId=34746546e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34746546e0, replyNumber=0, likeNumber=62, createdTime=2012-09-28, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34746546e0, moduleTitle=PNAS：糖尿病治疗新药靶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34746546e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989898, encodeId=3460198989889, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=STM：FGF21有望成为糖尿病治疗新靶点, objectType=article, longId=3542, objectId=91c23542fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91c23542fb, replyNumber=0, likeNumber=0, createdTime=2012-05-22, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91c23542fb, moduleTitle=STM：FGF21有望成为糖尿病治疗新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91c23542fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989902, encodeId=c07a198990283, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=脂肪酸合成酶或成糖尿病治疗新靶标, objectType=article, longId=4119, objectId=ff854119fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff854119fb, replyNumber=0, likeNumber=68, createdTime=2012-03-08, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff854119fb, moduleTitle=脂肪酸合成酶或成糖尿病治疗新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff854119fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989901, encodeId=c834198990148, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=PLoS One：TBC1D3蛋白将给Ⅱ型糖尿病治疗带来希望, objectType=article, longId=4117, objectId=a5bc411e36, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5bc411e36, replyNumber=0, likeNumber=76, createdTime=2012-03-30, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5bc411e36, moduleTitle=PLoS One：TBC1D3蛋白将给Ⅱ型糖尿病治疗带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5bc411e36)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989904, encodeId=6ad31989904d5, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=翁建平：强化胰岛素方案改变全球糖尿病治疗策略, objectType=article, longId=4770, objectId=c4fe4e708b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4fe4e708b, replyNumber=0, likeNumber=75, createdTime=2012-09-02, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4fe4e708b, moduleTitle=翁建平：强化胰岛素方案改变全球糖尿病治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4fe4e708b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989896, encodeId=757f1989896d1, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=糖尿病治疗潜在新靶标：糖异生通路和PEPCK1, objectType=article, longId=2826, objectId=5e8a2826b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e8a2826b8, replyNumber=0, likeNumber=80, createdTime=2011-11-30, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e8a2826b8, moduleTitle=糖尿病治疗潜在新靶标：糖异生通路和PEPCK1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e8a2826b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989899, encodeId=3489198989924, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=Pancreas：胰岛稳态蛋白或是1型糖尿病治疗新靶点, objectType=article, longId=3672, objectId=32f636e2a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f636e2a8, replyNumber=0, likeNumber=0, createdTime=2012-01-22, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f636e2a8, moduleTitle=Pancreas：胰岛稳态蛋白或是1型糖尿病治疗新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f636e2a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989897, encodeId=b80a198989e7f, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=减重手术：2型糖尿病治疗史上的又一座里程碑, objectType=article, longId=3021, objectId=5578302189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5578302189, replyNumber=0, likeNumber=80, createdTime=2012-02-06, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5578302189, moduleTitle=减重手术：2型糖尿病治疗史上的又一座里程碑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5578302189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989895, encodeId=965e19898959f, content=<a href='/topic/show?id=3207e6735ae' target=_blank style='color:#2F92EE;'>#糖尿病治疗#</a>, objectTitle=FDA批准2型糖尿病治疗新药DPP-4抑制剂Linagliptin, objectType=article, longId=2606, objectId=f8c826063a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8c826063a, replyNumber=0, likeNumber=96, createdTime=2011-10-03, rootId=0, userName=zhanglin3079, userId=e6a1280, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8c826063a, moduleTitle=FDA批准2型糖尿病治疗新药DPP-4抑制剂Linagliptin, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8c826063a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖尿病治疗

2020-05-29

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

J Diabetes：糖尿病治疗模式变革即将到来？

2013-01-22

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

Cell Metab：胰岛细胞酶蛋白Bace2成糖尿病治疗新药靶

2012-12-11

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

Lancet：质量改善策略可改善糖尿病治疗

2012-08-22

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

Cell Metab：TXNIP分子为糖尿病治疗提供新的靶点

2012-10-21

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

成人2型糖尿病治疗药物Jentadueto获FDA批准

2012-12-18

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

PNAS：糖尿病治疗新药靶

2012-09-28

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

STM：FGF21有望成为糖尿病治疗新靶点

2012-05-22

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

脂肪酸合成酶或成糖尿病治疗新靶标

2012-03-08

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

PLoS One：TBC1D3蛋白将给Ⅱ型糖尿病治疗带来希望

2012-03-30

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

翁建平：强化胰岛素方案改变全球糖尿病治疗策略

2012-09-02

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

糖尿病治疗潜在新靶标：糖异生通路和PEPCK1

2011-11-30

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

Pancreas：胰岛稳态蛋白或是1型糖尿病治疗新靶点

2012-01-22

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

减重手术：2型糖尿病治疗史上的又一座里程碑

2012-02-06

zhanglin3079 (审核中...)

前往app查看评论内容

#糖尿病治疗#

FDA批准2型糖尿病治疗新药DPP-4抑制剂Linagliptin

2011-10-03

科室
- - 订阅+
  - 更多科室
工具
服务